Embecta Corp.
$9.6
▲
0.68%
2026-04-21 06:37:01
www.embecta.com
NMS: EMBC
Explore Embecta Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$568.51 M
Current Price
$9.6
52W High / Low
$15.55 / $8.47
Stock P/E
4.08
Book Value
$-10.35
Dividend Yield
6.25%
ROCE
35.74%
ROE
-13.73%
Face Value
—
EPS
$2.36
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
1,850
Beta
1.1
Debt / Equity
-2.2
Current Ratio
2.64
Quick Ratio
1.73
Forward P/E
3.07
Price / Sales
0.49
Enterprise Value
$1.73 B
EV / EBITDA
4.73
EV / Revenue
1.6
Rating
None
Target Price
$16.67
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AngioDynamics, Inc. | $10.79 | — | $449.55 M | — | -11.8% | -17.47% | $13.99 / $8.36 | $4.16 |
| 2. | AptarGroup, Inc. | $125.33 | 21.29 | $8.05 B | 1.47% | 12.5% | 15.1% | $164.28 / $103.23 | $41.56 |
| 3. | LeMaitre Vascular, Inc. | $115 | 44.97 | $2.6 B | 0.87% | 11.72% | 15.8% | $118.01 / $78.01 | $17.28 |
| 4. | Warby Parker Inc. | $25.89 | 1,889.51 | $3.1 B | — | -0.93% | 0.46% | $31 / $13.63 | $3 |
| 5. | Align Technology, Inc. | $194.19 | 34.46 | $14 B | — | 13.57% | 10.39% | $208.31 / $122 | $56.74 |
| 6. | Intuitive Surgical, Inc. | $487.85 | 62.04 | $174.03 B | — | 15.96% | 16.69% | $603.88 / $427.84 | $50.19 |
| 7. | Pulse Biosciences, Inc. | $23.73 | — | $1.61 B | — | -88.83% | -74.45% | $26.3 / $12.56 | $1.19 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 261.2 M | 264 M | 295.5 M | 259 M | 261.9 M |
| Operating Profit | 76.3 M | 64.3 M | 105 M | 73.7 M | 53.4 M |
| Net Profit | 44.1 M | 26.4 M | 45.5 M | 23.5 M | 0 M |
| EPS in Rs | 0.74 | 0.45 | 0.77 | 0.4 | 0 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.08 B | 1.12 B | 1.12 B | 1.13 B |
| Operating Profit | 296.4 M | 285 M | 224 M | 368.5 M |
| Net Profit | 95.4 M | 78.3 M | 70.4 M | 223.6 M |
| EPS in Rs | 1.61 | 1.32 | 1.19 | 3.78 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.09 B | 1.29 B | 1.21 B | 1.09 B |
| Total Liabilities | 1.74 B | 2.02 B | 2.04 B | 1.98 B |
| Equity | -651.2 M | -738.9 M | -821.7 M | -891.4 M |
| Current Assets | 631.4 M | 761 M | 749.1 M | 664.7 M |
| Current Liabilities | 261.5 M | 374 M | 353.5 M | 301 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 191.7 M | 35.7 M | 67.7 M | 412.2 M |
| Investing CF | -9.3 M | -15.8 M | -26.5 M | -24 M |
| Financing CF | -226.7 M | -73.4 M | -48.7 M | -48 M |
| Free CF | 182.4 M | 19.9 M | 41.2 M | 388.2 M |
| Capex | -9.3 M | -15.8 M | -26.5 M | -24 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.21% | -0.77% | — | — |
| Earnings Growth % | 11.22% | -68.52% | — | — |
| Profit Margin % | 6.97% | 6.28% | 19.8% | — |
| Operating Margin % | 25.38% | 19.99% | 32.63% | — |
| Gross Margin % | 65.46% | 66.91% | 68.61% | — |
| EBITDA Margin % | 17.16% | 21.89% | 29.61% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-02-27 | $0.15 |
| 2025-12-05 | $0.15 |
| 2025-08-29 | $0.15 |
| 2025-05-28 | $0.15 |
| 2025-02-28 | $0.15 |
Stock Splits
No stock split history available.